Health
Drug May Reduce Tumor Volume in Neurofibromatosis – Technology Networks
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers have shown that the drug, cabozantinib, reduces tumor volume…
Based on preclinical studies of an investigational drug to treat peripheral nerve tumors, researchers at Children’s Hospital of Philadelphia (CHOP) as part of the Neurofibromatosis Clinical Trials Consortium have shown that the drug, cabozantinib, reduces tumor volume and pain in patients with the genetic disorder neurofibromatosis type 1 (NF1). The results of the Phase 2 clinical trial, co-chaired by Michael J. Fisher, MD at CHOP, were published recently in Nature Medicine.
“This is the second…
-
Noosa News20 hours agoRallies under way as nationwide support for Palestine surges
-
General22 hours agoNRL live updates: Newcastle Knights vs Brisbane Broncos, Wests Tigers vs North Queensland Cowboys — blog, scores and stats
-
General23 hours agoFinnish performer crowned Air Guitar World Champion after 25-year drought
-
Noosa News23 hours agoMan charged with murder of Brisbane mother